← All organizations

Opexa Therapeutics

For profitWebsite ↗

Also known as: Opexa Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 1, 2012

Acquired by Acer Therapeutics → Zevra Therapeutics on Jul 3, 2017

Timeline

1980s

Jun 1, 1986
Opexa Therapeutics— Founded

2010s

Jul 3, 2017
Acer Therapeutics— Acquired By

2020s

Nov 20, 2023
Zevra Therapeutics— Now

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT01684761Lead sponsorPhase 2Aug 1, 2012
NCT01684761Study directorPhase 2Aug 1, 2012
NCT00595920Lead sponsorPhase 2Nov 1, 2007
NCT00245622Lead sponsorPhase 2May 1, 2006
NCT00245622Study directorPhase 2May 1, 2006
NCT00587691Lead sponsorPhase 1/Phase 2Jul 1, 2002
NCT00587691Study directorPhase 1/Phase 2Jul 1, 2002

Details

Founded: Houston, TX, US Jun 1, 1986
Last known activity: Aug 1, 2012